belle medical glp 1 Belle Medical introduces semaglutide, a
Description
doi: 10.1536/ihj.19-327 39 ZhouYHeXChenYHuangYWuLHeJ
More research is needed to understand the effect of other agonists, as cancer research is lacking
Wang, C
Fisher M, Petrie MC, Ambery PD, Donaldson J, Ye J, McMurray JJ
Collectively, this evidence is consistent with the hypothesis that semaglutides primary value in the context of cognitive health may lie in prevention rather than treatment, particularly for cognitive decline driven by vascular and metabolic dysfunctions
Many are turning to acquisitions or in-licensing
